Recurrent corneal erosion medical therapy

Jump to navigation Jump to search

Recurrent Corneal Erosion Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Recurrent Corneal Erosion from other Diseases

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Recurrent corneal erosion medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Recurrent corneal erosion medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Recurrent corneal erosion medical therapy

CDC on Recurrent corneal erosion medical therapy

Recurrent corneal erosion medical therapy in the news

Blogs on Recurrent corneal erosion medical therapy

Directions to Hospitals Treating Recurrent corneal erosion

Risk calculators and risk factors for Recurrent corneal erosion medical therapy

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[2]

Medical Therapy

Water or saline eye drops tend to be ineffective, as with the eye generally profusely watering, the type of tears being produced have little adhesive property. Rather a better quality of tear is required with higher wetting ability (i.e greater amount of glycoproteins) and so artificial tears (eg viscotears) are applied frequently. Whilst individual episodes may settle within a few hours or days, additional episodes (as the name suggests) will recur at intervals.

Patients with recalcitrant recurrent corneal erosions often show increased levels of matrix metalloproteinase (MMP) enzymes.[1] These enzymes dissolve the basement membrane and fibrils of the hemidesmosomes, which can lead to the separation of the epithelial layer. Treatment with oral tetracycline antibiotics (such as doxycycline or oxytetracycline) together with a topical corticosteroid (such as prednisolone), reduce MMP activity and may rapidly resolve and prevent further episodes in cases unresponsive to conventional therapies. [2][3]

References

  1. Ramamurthi S, Rahman M, Dutton G, Ramaesh K (2006). "Pathogenesis, clinical features and management of recurrent corneal erosions". Eye. 20 (6): 635–44. PMID 16021185.
  2. Hope-Ross M, Chell P, Kervick G, McDonnell P, Jones H (1994). "Oral tetracycline in the treatment of recurrent corneal erosions". Eye. 8 (Pt 4): 384–8. PMID 7821456.
  3. Dursun D, Kim M, Solomon A, Pflugfelder S (2001). "Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids". Am J Ophthalmol. 132 (1): 8–13. PMID 11438047.

Template:WH Template:WS